By using the final ROC curve of these serum biomarkers to provide reliable clinical indicators, we can conclude that CEA and CYFRA 21-1 have cut-off values of 1.005 ng/ml and 135.31 ng/ml, respectively, in lung cancer patients with mediastinal lymph node metastasis. The gene discussed is CEACAM5; the disease is lung cancer.